3
Mar 2026
Pro-inflammatory M1 macrophages involved in immune responses accelerate the progression of melanoma through the extracellular vesicles they secrete, a recent study from the University of Eastern Finland shows. The findings were published in Cell Communication and Signaling.
3
Mar 2026
This study uncovers epigenetic changes during puberty that correlate with insulin resistance, offering insights into childhood obesity and metabolic risk.
3
Mar 2026
Combining gait, handwriting, and speech analysis, this AI framework enhances early Parkinson's disease detection, addressing clinical challenges effectively.
3
Mar 2026
This review examines how nature exposure impacts brain function, stress reduction, and emotional well-being, highlighting gaps and future research directions.
3
Mar 2026
A sweeping new peer-reviewed study published in Genomic Psychiatry has introduced a concept that could reshape how psychiatrists and geneticists think about mental illness: genetic specificity.
3
Mar 2026
Coronaviruses not only use the machinery of the human cells they infect: they modify it to achieve optimal conditions to produce viral proteins and thus spread more quickly. This is the main conclusion of a study by Pompeu Fabra University published in Nature Communications.
3
Mar 2026
Starting elementary school is a major milestone, but it can be a difficult transition as children can experience separation anxiety or have trouble adapting to school rules and structure. However, a team led by Penn State researchers found that consistent routines in the home can reduce the likelihood that children will struggle with the school transition.
3
Mar 2026
A new study of what families think about virtual reality (VR) technologies reveals that parents want more research-based information on how VR technologies may influence brain and behavioral development. Families also placed a higher value on VR features that increase physical activity, compared to features such as educational content.
2
Mar 2026
Azenta, Inc. today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta’s B Medical Systems business to THELEMA S.À R.L., for a purchase price of US$63 million.
2
Mar 2026
Neuropathy – chronic pain, numbness and tingling in the hands and feet – is a challenging fact of life for many patients with Type 1 diabetes.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
